Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
8.42
+1.05 (14.25%)
At close: Oct 30, 2025, 4:00 PM EDT
8.34
-0.08 (-0.95%)
After-hours: Oct 30, 2025, 7:59 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $600.42 million as of October 30, 2025. Its market cap has increased by 263.08% in one year.
Market Cap
600.42M
Enterprise Value
401.75M
1-Year Change
263.08%
Ranking
Category
Stock Price
$8.42
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $600.42M, a decrease of -23.31%. That is a compound annual growth rate of -6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 525.54M | 239.38% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.38B |
| Johnson & Johnson | 453.16B |
| AbbVie | 404.06B |
| UnitedHealth Group | 313.44B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 217.85B |